Paul P. Doghramji, MD, discusses the underdiagnosis of narcolepsy especially among younger individuals and how clinicians can address this.

Some women climax into laughter, tears, or pain — and science is finally explaining why that doesn’t mean something is wrong.

Wealthy tech bro turned antivax crank Steve Kirsch attacked Paul Offit for refusing to debate antivaxxers, while Dr. Mike was "surrounded" by MAHA stans. These recent events led me to revisit the ques ...

The scope of all human knowledge is, understandably, so massive that no one person can manage to fully comprehend even a ...

MediaRadar today unveiled its Data Cloud, a breakthrough in advertising data interoperability that transforms how Marketing Intelligence is accessed, activated and scaled in an AI-driven market. As ...

Axsome stock jumped Wednesday after the biotech firm said its Alzheimer's disease agitation drug will get a priority review.

Her family brought her to the hospital, but they sent her home a month later, with a diagnosis that made no sense at all.

The FDA has granted Breakthrough Therapy designation to alixorexton for the treatment of narcolepsy type 1 (NT1).

In the video, Renee Nicole Good can be seen smiling at the officer moments before he opens fire. MINNEAPOLIS — Cellphone ...

New Drug Application (NDA) submission on track for January 2026 NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome ...

In a polarized country, high-ranking officials were offering definitive, and starkly contrasting, accounts long before the ...

An AI-generated video with over 5 million views on social media purports to show Venezuelans celebrating Nicolas Maduro's ...